NovaBay Pharmaceuticals (NBY) PT Lowered to $3.75 at Roth Capital
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
NovaBay Pharmaceuticals (NBY) PT Lowered to $5 at Ascendiant Capital
May 14, 2018 1:52 AM EDTAscendiant Capital lowered its price target on NovaBay Pharmaceuticals (NYSE: NBY) to $5.00 (from $6.00) while maintaining a Buy rating.
... MoreNovaBay Pharmaceuticals (NBY) PT Lowered to $4.50 at Laidlaw
May 11, 2018 7:48 AM EDTLaidlaw lowered its price target on NovaBay Pharmaceuticals (NYSE: NBY) to $4.50 (from $6.00) while maintaining a Buy rating.
... MoreNovaBay Pharmaceuticals (NBY) PT Lowered to $5 at H.C. Wainwright
May 11, 2018 7:28 AM EDTH.C. Wainwright lowered its price target on NovaBay Pharmaceuticals (NYSE: NBY) to $5.00 (from $6.00) while maintaining a Buy rating.
... More